Sweeney, R. W., Fitzpatrick, J. T., Omstead, A. N., Zheng, P., Gorbunova, A., Wagner, P. L., … Zaidi, A. H. (2022). Sitravatanib enhances immune checkpoint blockade in a de novo esophageal adenocarcinoma model. In CANCER IMMUNOLOGY RESEARCH (Vol. 10).

Sweeney, Ryan W., John T. Fitzpatrick, Ashten N. Omstead, Ping Zheng, Anastasia Gorbunova, Patrick L. Wagner, Juliann E. Kosovec, Blair A. Jobe, Ronan J. Kelly, and Ali H. Zaidi. “Sitravatanib enhances immune checkpoint blockade in a de novo esophageal adenocarcinoma model.” In CANCER IMMUNOLOGY RESEARCH, Vol. 10, 2022.

Sweeney RW, Fitzpatrick JT, Omstead AN, Zheng P, Gorbunova A, Wagner PL, et al. Sitravatanib enhances immune checkpoint blockade in a de novo esophageal adenocarcinoma model. In: CANCER IMMUNOLOGY RESEARCH. 2022.

Sweeney, Ryan W., et al. “Sitravatanib enhances immune checkpoint blockade in a de novo esophageal adenocarcinoma model.” CANCER IMMUNOLOGY RESEARCH, vol. 10, no. 12, 2022.

Sweeney RW, Fitzpatrick JT, Omstead AN, Zheng P, Gorbunova A, Wagner PL, Kosovec JE, Jobe BA, Kelly RJ, Zaidi AH. Sitravatanib enhances immune checkpoint blockade in a de novo esophageal adenocarcinoma model. CANCER IMMUNOLOGY RESEARCH. 2022.